|
Jan 20, 2011

Meaningful Use mandates quality reporting data be
pulled directly from EHRs. Hospitals must have
extensive knowledge of both the submission
process and the standards. As such, MEDITECH's
collaborative solutions provider, Medisolv, now
provides customers with the quality reporting
expertise for all stages of Meaningful Use, as
well as CMS and The Joint Commission quality
reporting programs.
Click here for customer
testimonials and more information about achieving
Meaningful Use using Medisolv's reporting
solution.
MEDITECH:
Preparing You for Stage 2
Dec 5, 2011

While MEDITECH continues to support our customers
attesting for Stage 1 Meaningful Use, we're also
diligently preparing for Stage 2. We have
assembled two brief, yet comprehensive, overview
documents for our customers: MEDITECH Prepares You for
Stage 2 of Meaningful Use for Eligible Hospitals and MEDITECH Prepares You for
Stage 2 of Meaningful Use for Eligible
Professionals. While these documents are
obviously somewhat preliminary in nature (the
government's Final Ruling is still several months
away from completion), they do provide our
customers with valuable insights into MEDITECH's
approaches and plans. We urge you to read them
and to discuss the content with your relevant
MEDITECH customer support representatives.
Nov 30, 2011

In an effort to make it easier for health care
providers and hospitals to qualify for meaningful
use incentive payments, HHS has announced major policy changes.
Under current regulations, eligible health care
providers that attest to Stage 1 of the Medicare
EHR incentive program this year would need to
meet Stage 2 requirements in 2013. However,
health care providers who attest to Stage 1 in
2012 would not need to meet Stage 2 requirements
until 2014, but they still would be eligible for
the same total incentive payment amount.
Read More>
Nov 10, 2011

Check out the latest updates and attestation
information from CMS. Payment and
registration data are now available as maps and
reports for easier tracking.
Read More>
|
|
|
|